Product Information
XALATAN 0.005% EYE DROPS is a brand product labeled by Viatris Specialty LLC, priced at $108.3422 per ML under NDC 58151041935. Its NADAC has been published 95 times since Dec 11, 2024.
FDA first approved this application on Jun 5, 1996. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the Latanoprost market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 ug/mL
Manufacturer
Viatris Specialty LLCNDC
58151041935
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
LATANOPROSTApproval Type
New Drug (NDA)
FDA Application
NDA020597FDA Approved
6/5/1996
TE Code
AT
On Market Since
10/22/2024
Price Statistics
The NADAC for XALATAN 0.005% EYE DROPS has been published 95 times since Dec 11, 2024, and over the history we have for it it has risen 6.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $108.3422 per ML |
|---|---|
| All-time high | $108.4434 (May 13, 2026) |
| All-time low | $101.7102 (Dec 11, 2024) |
| 52-week high | $108.4434 |
| 52-week low | $103.2558 |
| Median price | $103.7464 |
| Average price | $105.3768 |
| Largest weekly change | +5.0% (Jan 7, 2026) |
| Weeks tracked | 95 |
| Tracking since | Dec 11, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viatris Specialty LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Latanoprost market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of XALATAN 0.005% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for XALATAN 0.005% EYE DROPS, manufactured by Viatris Specialty LLC, is $108.3422 per ML (NDC 58151041935), effective Sep 30, 2026.
How has the price of XALATAN 0.005% EYE DROPS changed over time?
Over the history we have for it, the NADAC for XALATAN 0.005% EYE DROPS has risen 6.5%. It has been tracked across 95 weekly CMS publications since Dec 11, 2024.
What are the highest and lowest recorded NADAC prices for XALATAN 0.005% EYE DROPS?
Since Dec 11, 2024, the NADAC for XALATAN 0.005% EYE DROPS has ranged from a low of $101.7102 (Dec 11, 2024) to a high of $108.4434 (May 13, 2026), with a median of $103.7464 per ML.
Are there cheaper alternatives to XALATAN 0.005% EYE DROPS?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LATANOPROST 0.005% EYE DROPS, is $1.5751 per ML — about 99% below XALATAN 0.005% EYE DROPS.
Who manufactures XALATAN 0.005% EYE DROPS?
XALATAN 0.005% EYE DROPS (NDC 58151041935) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.